Unknown

Dataset Information

0

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells.


ABSTRACT: TAE226, a bis-anilino pyrimidine compound, has been developed as an inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor-I receptor (IGF-IR). In this study, we investigated the effect of TAE226 on non-small-cell lung cancer (NSCLC), especially focusing on the EGFR mutational status. TAE226 was more effective against cells with mutant EGFR, including the T790M mutant, than against cells with wild-type one. TAE226 preferentially inhibited phospho-EGFR and its downstream signaling mediators in the cells with mutant EGFR than in those with wild-type one. Phosphorylation of FAK and IGF-IR was not inhibited at the concentration at which the proliferation of EGFR-mutant cells was inhibited. Results of the in vitro binding assay indicated significant differences in the affinity for TAE226 between the wild-type and L858R (or delE746_A750) mutant, and the reduced affinity of ATP to the L858R (or delE746_A750) mutant resulted in good responsiveness of the L858R (or delE746_A750) mutant cells to TAE226. Of interest, the L858R/T790M or delE746_A750/T790M mutant enhanced the binding affinity for TAE226 compared with the L858R or delE746_A750 mutant, resulting in the effectiveness of TAE226 against T790M mutant cells despite the T790M mutation restoring the ATP affinity for the mutant EGFR close to that for the wild-type. TAE226 also showed higher affinity of about 15-fold for the L858R/T790M mutant than for the wild-type one by kinetic interaction analysis. The anti-tumor effect against EGFR-mutant tumors including T790M mutation was confirmed in mouse models without any significant toxicity. In summary, we showed that TAE226 inhibited the activation of mutant EGFR and exhibited anti-proliferative activity against NSCLCs carrying EGFR mutations, including T790M mutation.

SUBMITTER: Otani H 

PROVIDER: S-EPMC4474554 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Otani Hiroki H   Yamamoto Hiromasa H   Takaoka Munenori M   Sakaguchi Masakiyo M   Soh Junichi J   Jida Masaru M   Ueno Tsuyoshi T   Kubo Takafumi T   Asano Hiroaki H   Tsukuda Kazunori K   Kiura Katsuyuki K   Hatakeyama Shinji S   Kawahara Eiji E   Naomoto Yoshio Y   Miyoshi Shinichiro S   Toyooka Shinichi S  

PloS one 20150619 6


TAE226, a bis-anilino pyrimidine compound, has been developed as an inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor-I receptor (IGF-IR). In this study, we investigated the effect of TAE226 on non-small-cell lung cancer (NSCLC), especially focusing on the EGFR mutational status. TAE226 was more effective against cells with mutant EGFR, including the T790M mutant, than against cells with wild-type one. TAE226 preferentially inhibited phospho-EGFR and its downstream signalin  ...[more]

Similar Datasets

| S-EPMC2582962 | biostudies-literature
| S-EPMC4027575 | biostudies-literature
| S-EPMC2879581 | biostudies-literature
| S-EPMC5150691 | biostudies-literature
| S-EPMC5528336 | biostudies-other
| S-EPMC4929832 | biostudies-literature
| S-EPMC4741607 | biostudies-literature
| S-EPMC3272303 | biostudies-literature
| S-EPMC6239293 | biostudies-literature
| S-EPMC7979775 | biostudies-literature